113 related articles for article (PubMed ID: 3902672)
1. Once daily timolol in the prophylaxis of angina pectoris.
Given-Wilson R; Joy M
Int J Cardiol; 1985 Oct; 9(2):191-8. PubMed ID: 3902672
[TBL] [Abstract][Full Text] [Related]
2. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
3. The effect of timolol vs placebo on angina pectoris.
Aronow WS; Turbow M; Van Camp S; Lurie M; Whittaker K
Circulation; 1980 Jan; 61(1):66-9. PubMed ID: 6765920
[TBL] [Abstract][Full Text] [Related]
4. Exercise duration to angina at two and twelve hours after timolol.
Aronow WS; Plasencia G; Wong R; Landa D
Clin Pharmacol Ther; 1981 Feb; 29(2):155-9. PubMed ID: 7006883
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of bevantolol for chronic, stable angina pectoris.
Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
Am J Cardiol; 1986 Nov; 58(12):28E-34E. PubMed ID: 2878598
[TBL] [Abstract][Full Text] [Related]
6. Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group.
Nordlander R; Walter M
Eur Heart J; 1994 Jan; 15(1):108-13. PubMed ID: 8174569
[TBL] [Abstract][Full Text] [Related]
7. Verapamil administered twice daily in stable angina pectoris.
Tan AT; Quek S
Chest; 1984 Jan; 85(1):55-8. PubMed ID: 6360575
[TBL] [Abstract][Full Text] [Related]
8. A comparison of once and twice daily atenolol for angina pectoris.
Boyle RM; Bray CL; Naqvi N; Croxson RS; Cruickshank JM
Int J Cardiol; 1983 Apr; 3(1):25-35. PubMed ID: 6343259
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
10. Effect of timolol on cardiopulmonary exercise performance in men after myocardial infarction.
Barvik S; Dickstein K; Aarsland T; Vik-Mo H
Am J Cardiol; 1992 Jan; 69(3):163-8. PubMed ID: 1731452
[TBL] [Abstract][Full Text] [Related]
11. A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris.
Maltz MB; Dymond DS; Nathan AW; Camm AJ
Eur Heart J; 1987 Dec; 8 Suppl M():37-42. PubMed ID: 2967184
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of long-acting and conventional propranolol on stress-induced angina pectoris and on frequency of ventricular premature beats.
Hansteen V; Endresen K; Hellemann H; Eriksen II; Brorssen O; Ekeli T; Day M; Baber NS
Br J Clin Pharmacol; 1984 May; 17(5):579-84. PubMed ID: 6203546
[TBL] [Abstract][Full Text] [Related]
13. Observations on the warm up phenomenon in angina pectoris.
Joy M; Cairns AW; Sprigings D
Br Heart J; 1987 Aug; 58(2):116-21. PubMed ID: 3620250
[TBL] [Abstract][Full Text] [Related]
14. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
Walker JM; Curry PV; Bailey AE; Steare SE
Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
[TBL] [Abstract][Full Text] [Related]
15. Double-blind randomised crossover trial comparing isosorbide dinitrate cream and oral sustained-release tablets in patients with angina pectoris.
Handler CE; Sullivan ID
Int J Cardiol; 1985 Feb; 7(2):149-57. PubMed ID: 3882583
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory monitoring and exercise testing in the evaluation of a new long-acting calcium ion antagonist KB-944 (Fostedil) for the treatment of exertional angina pectoris.
Khurmi NS; Bowles MJ; O'Hara MJ; Lahiri A; Raftery EB
Int J Cardiol; 1985 Nov; 9(3):289-302. PubMed ID: 3902675
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
Chaitman BR
J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
[TBL] [Abstract][Full Text] [Related]
18. Effects of nifedipine on myocardial perfusion during exercise in chronic stable angina pectoris.
Rice KR; Gervino E; Jarisch WR; Stone PH
Am J Cardiol; 1990 May; 65(16):1097-101. PubMed ID: 2184649
[TBL] [Abstract][Full Text] [Related]
19. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
Thadani U; Ezekowitz M; Fenney L; Chiang YK
Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
[TBL] [Abstract][Full Text] [Related]
20. Double-blind comparison of once daily betaxolol versus propranolol four times daily in stable angina pectoris. Betaxolol Investigators Group.
Narahara KA
Am J Cardiol; 1990 Mar; 65(9):577-82. PubMed ID: 2178381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
